Medical device companies are battling low utilization, economic uncertainty in Europe and headwinds in the U.S. in the form of the medical device tax and changes wrought by healthcare reform. In the midst of it all, Edwards Lifesciences (NYSE:EW) showed that the launch of its highly anticipated Sapien transcatheter valve implantation system could not have […]
Two events this week prompted investors to disproportionately reward and punish stocks of two medical technology companies: Edwards Lifesciences (NYSE:EW) and St. Jude Medical (NYSE:STJ). One piece of news was largely expected — a panel at the U.S. Food and Drug Administration gave a thumbs up to the expanded indication for Edwards Lifesciences’ SAPIEN transcatheter […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The protracted battle over transcatheter heart valves between Medtronic Inc. (NYSE:MDT) and Edwards Lifesciences Inc. (NYSE:EW) will be decided in the streets rather than the courts.
Edwards Lifesciences Corp. got a boost this week after the New England Journal of Medicine published a study showing that the company's catheter-delivered aortic valve replacement is much safer for elderly patients than standard treatments. Edwards and Fridley, Minnesota-based Medtronic (and other companies) are racing to get the first percutaneous heart valves to market.